Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chemical characterization of inks in skin reactions to tattoo.
Colboc H, Bazin D, Reguer S, Lucas IT, Moguelet P, Amode R, Jouanneau C, Soria A, Chasset F, Amsler E, Pecquet C, Aractingi S, Bellot-Gurlet L, Deschamps L, Descamps V, Kluger N. Colboc H, et al. Among authors: pecquet c. J Synchrotron Radiat. 2022 Nov 1;29(Pt 6):1436-1445. doi: 10.1107/S1600577522008165. Epub 2022 Oct 4. J Synchrotron Radiat. 2022. PMID: 36345752 Free PMC article.
Prevalence and Description of the Skin Reactions Associated with Adhesives in Diabetes Technology Devices in an Adult Population: Results of the CUTADIAB Study.
Diedisheim M, Pecquet C, Julla JB, Carlier A, Potier L, Hartemann A, Jacqueminet S, Vidal-Trecan T, Gautier JF, Dubois Laforgue D, Fagherazzi G, Roussel R, Larger E, Sola-Gazagnes A, Riveline JP. Diedisheim M, et al. Among authors: pecquet c. Diabetes Technol Ther. 2023 Apr;25(4):279-286. doi: 10.1089/dia.2022.0513. Epub 2023 Feb 24. Diabetes Technol Ther. 2023. PMID: 36763338
Oncogenic CALR mutant C-terminus mediates dual binding to the thrombopoietin receptor triggering complex dimerization and activation.
Papadopoulos N, Nédélec A, Derenne A, Şulea TA, Pecquet C, Chachoua I, Vertenoeil G, Tilmant T, Petrescu AJ, Mazzucchelli G, Iorga BI, Vertommen D, Constantinescu SN. Papadopoulos N, et al. Among authors: pecquet c. Nat Commun. 2023 Apr 5;14(1):1881. doi: 10.1038/s41467-023-37277-3. Nat Commun. 2023. PMID: 37019903 Free PMC article.
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Pecquet C, Papadopoulos N, Balligand T, Chachoua I, Tisserand A, Vertenoeil G, Nédélec A, Vertommen D, Roy A, Marty C, Nivarthi H, Defour JP, El-Khoury M, Hug E, Majoros A, Xu E, Zagrijtschuk O, Fertig TE, Marta DS, Gisslinger H, Gisslinger B, Schalling M, Casetti I, Rumi E, Pietra D, Cavalloni C, Arcaini L, Cazzola M, Komatsu N, Kihara Y, Sunami Y, Edahiro Y, Araki M, Lesyk R, Buxhofer-Ausch V, Heibl S, Pasquier F, Havelange V, Plo I, Vainchenker W, Kralovics R, Constantinescu SN. Pecquet C, et al. Blood. 2023 Feb 23;141(8):917-929. doi: 10.1182/blood.2022016846. Blood. 2023. PMID: 36356299 Free PMC article.
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis.
Lecomte S, Devreux J, de Streel G, van Baren N, Havelange V, Schröder D, Vaherto N, Vanhaver C, Vanderaa C, Dupuis N, Pecquet C, Coulie PG, Constantinescu SN, Lucas S. Lecomte S, et al. Among authors: pecquet c. Blood. 2023 Feb 2;141(5):490-502. doi: 10.1182/blood.2022017097. Blood. 2023. PMID: 36322928 Free PMC article.
Insulin allergy: a diagnostic and therapeutic strategy based on a retrospective cohort and a case-control study.
Sola-Gazagnes A, Pecquet C, Berré S, Achenbach P, Pierson LA, Virmoux-Buisson I, M'Bemba J, Elgrably F, Moguelet P, Boitard C, Caillat-Zucman S, Laanani M, Coste J, Larger E, Mallone R. Sola-Gazagnes A, et al. Among authors: pecquet c. Diabetologia. 2022 Aug;65(8):1278-1290. doi: 10.1007/s00125-022-05710-9. Epub 2022 May 4. Diabetologia. 2022. PMID: 35505238
Multiple cases of sensitization to an antiseptic containing chlorhexidine digluconate/benzalkonium chloride/benzyl alcohol with different profiles of sensitization in adults and children.
Beaumont C, Darrigade AS, Barbaud A, Collet E, Raison-Peyron N, Bourrain JL, Assier H, Giordano-Labadie F, Bara-Passot C, Milpied B, Tétart F, Armingaud P, Castelain F, Benkalfate L, Boulard C, Delaunay J, Mathelier-Fusade P, Pecquet C, Pralong P, Vital-Durand D, Genillier Foin N, Lefèvre MA, Hacard F, Nosbaum A, Pasteur J, Valois A, Vigan M, Ferrier le Bouëdec MC; REVIDAL-GERDA Network. Beaumont C, et al. Among authors: pecquet c. Contact Dermatitis. 2022 Jul;87(1):62-70. doi: 10.1111/cod.14085. Epub 2022 Mar 29. Contact Dermatitis. 2022. PMID: 35213760
Targets in MPNs and potential therapeutics.
Levy G, Mambet C, Pecquet C, Bailly S, Havelange V, Diaconu CC, Constantinescu SN. Levy G, et al. Among authors: pecquet c. Int Rev Cell Mol Biol. 2022;366:41-81. doi: 10.1016/bs.ircmb.2021.06.004. Epub 2021 Sep 23. Int Rev Cell Mol Biol. 2022. PMID: 35153006
Degrading JAK2 in ALL by ruxolitinib-based PROTACs.
Constantinescu SN, Pecquet C. Constantinescu SN, et al. Among authors: pecquet c. Blood. 2021 Dec 9;138(23):2301-2302. doi: 10.1182/blood.2021012004. Blood. 2021. PMID: 34882211 Free article. No abstract available.
128 results